Cindy Leissinger is an Oncology physician affiliated with Tulane University. OpenAlex indexes 185 publications with 6,704 citations (h-index 35); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Sponsor: Carelon Research
- Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Sponsor: Carelon Research
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20251 payment
- PFIZER INC.Program year20251 payment
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
68.9%Vitamin K antagonist31.8%Warfarin Sodium100%Part D<11 patientsLow Molecular Weight Heparin15.9%Enoxaparin Sodium100%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
23.8%Antimetabolite14.6%Hydroxyurea100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug9.3%Celecoxib100%Part D<11 patientsOther
7.3%Iron Chelator7.3%Deferasirox100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1991–2012 per NIH RePORTER. The latest:
- Hemostasis Clinical Research Network Protocols
Tulane University of Louisiana
FY2012$15,782U01HL072274 - Hemostasis Clinical Research Network Protocols
Tulane University of Louisiana
FY2009$186,250U01HL072274 - Hemostasis Clinical Research Network Protocols
Tulane University of Louisiana
FY2007$186,250U01HL072274
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program
Journal of Thrombosis and Haemostasis
2022 - B cell–activating factor modulates the factor VIII immune response in hemophilia A
Journal of Clinical Investigation
2021 - Laboratory variability in the diagnosis of type 2 VWD variants
Journal of Thrombosis and Haemostasis
2020 - Acquired hemophilia <scp>A</scp>: Updated review of evidence and treatment guidance
American Journal of Hematology
2017 - Clinical outcomes in a cohort of patients with heparin‐induced thrombocytopenia
American Journal of Hematology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Roy Weiner, MD
Tulane University
Vadym Rusnak, MD
Tulane University
Alan Kaye, MD
Tulane University
Erik Castle, MD
Tulane University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”